Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Given the associations between chronic inflammation and epithelial cancer, we studied susceptibility to skin carcinogenesis in mice deficient for the pro-inflammatory cytokine TNF-alpha (refs. 5,6). TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation with DMBA and promotion with TPA or by repeated dosing with DMBA. TNF-alpha(-/-) mice developed 5-10% the number of tumors developed by wild-type mice during initiation/promotion and 25% of those in wild-type mice after repeated carcinogen treatment. TNF-alpha could influence tumor and stromal cells during tumor development. The early stages of TPA promotion are characterized by keratinocyte hyperproliferation and inflammation. These were diminished in TNF-alpha(-/-) mice. TNF-alpha was extensively induced in the epidermis, but not the dermis, in TPA-treated wild-type skin, indicating that dermal inflammation is controlled by keratinocyte TNF-alpha production. Deletion of a TNF-alpha inducible chemokine also conferred some resistance to skin tumor development. TNF-alpha has little influence on later stages of carcinogenesis, as tumors in wild-type and TNF-alpha(-/-) mice had similar rates of malignant progression. These data provide evidence that a pro-inflammatory cytokine is required for de novo carcinogenesis and that TNF-alpha is important to the early stages of tumor promotion. Strategies that neutralize TNF-alpha production may be useful in cancer treatment an…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCP1 is a critical chemoattractant responsible for the recruitment of macrophages into tumor and for angiogenesis in breast cancer [131, 132], and may contribute to indirect crosstalk between MSC and cancer cells via recruitment of tumor-resident macrophages.”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [132]
Citations
Cites
Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
Bradley, P. P., Priebat, D. A., Christensen, R. D., & Rothstein, G. (1982) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12506462 · Cited by 3,626
Correa, P. (1992) · PubMed · Cited by 3,216
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Self-citationLu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Self-citationEggermont, A. M., Schraffordt Koops, H., Liénard, D., Kroon, B. B., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 398
Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma Outcome
Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., & Salles, G. (1998) · Blood · doi:10.1182/blood.v91.10.3574 · Cited by 272
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Self-citationAnti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H., & Kollias, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6319 · Cited by 205
Self-citation
Cited by
Items 601–700 of 838
Tumor necrosis factor receptor 1 functions as a tumor suppressor
Chang, F., Lacey, M. R., Bouljihad, M. T., zu Bentrup, K. H., & Fortgang, I. S. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00209.2011 · Cited by 14
Memory T-Cell Responses and Survival in Human Cancer: Remember to Stay Alive
Camus, M., & Galon, J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6451-9_13 · Cited by 13
Systems biology perspectives on the carcinogenic potential of radiation
Barcellos‐Hoff, M. H., Adams, C., Balmain, A., Costes, S. V., Demaria, S., Illa-Bochaca, I., Mao, J., Ouyang, H., Sebastiano, C., & Tang, J. (2014) · Journal of Radiation Research · doi:10.1093/jrr/rrt211 · Cited by 14
Epidermal α6β4 integrin stimulates the influx of immunosuppressive cells during skin tumor promotion
Maalouf, S. W., Theivakumar, S., & Owens, D. M. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.02.009 · Cited by 15
Self-citationDiabetes-associated dysregulated cytokines and cancer
Wu, Y., Dong, Y., Liu, Y., & Vadgama, J. V. (2016) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000173 · Cited by 18
Chang, W., Jeng, J., Shieh, C., Tsai, Y., Ho, Y., Guo, H., Liu, H., Lee, C., Ho, S., & Wang, Y. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10113 · Cited by 14
Thomas, G., Tuk, B., Song, J., Truong, H. H., Gerritsen, H. C., de Gruijl, F. R., & Sterenborg, H. J. C. M. (2016) · Laboratory Animals · doi:10.1177/0023677216637305 · Cited by 15
Sá, M. C., de Matos, F. R., Conceição, T. S., Leitão, A. C. G. H., & Freitas, R. A. (2016) · International Endodontic Journal · doi:10.1111/iej.12640 · Cited by 13
TNF-α Promoter Single Nucleotide Polymorphisms in Gastroenteropancreatic Neuroendocrine Tumors
Berković, M. C., Čaćev, T., Zjačić-Rotkvić, V., & Kapitanović, S. (2006) · Neuroendocrinology · doi:10.1159/000097988 · Cited by 13
Brewer, J. D., Hoverson, A. R., & Roenigk, R. K. (2011) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.05024.x · Cited by 13
Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer
Mukaida, N., Sasakki, S.-I., & Popivanova, B. K. (2011) · Cancers · doi:10.3390/cancers3032811 · Cited by 14
p53, chemokines, and squamous cell carcinoma
Owens, D. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32719 · Cited by 13
Self-citationTopical application of valrubicin has a beneficial effect on developing skin tumors
Andersen, S. M., Rosada, C., Dagnæs‐Hansen, F., Laugesen, I. G., de Darkó, E., Dam, T. N., & Stenderup, K. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq122 · Cited by 13
Kuprash, D. V., Qin, Z., Ito, D., Grivennikov, S. I., Abe, K., Drutskaya, L. N., Blankenstein, T. J. F., & Nedospasov, S. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.023 · Cited by 13
Gering, K. M., Marx, J., Lennartz, K., Fischer, C., Rajewsky, M. F., & Kindler‐Röhrborn, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3780 · Cited by 13
Zhao, N., Guo, P., Tang, M. T. C., Yang, F., Zhang, T., & Mao, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1201167 · Cited by 12
Liu, Z., Wyffels, L., Barber, C., Wan, L., Xu, H. J., Hui, M. M., Furenlid, L. R., & Woolfenden, J. M. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.05.003 · Cited by 12
Effect of Suppressive Oligodeoxynucleotides on the Development of Inflammation-Induced Papillomas
Ikeuchi, H., Kinjo, T., & Klinman, D. M. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0290 · Cited by 12
Kisin, E. R., Yanamala, N. V. K., Rodin, D., Menas, A. L., Farcas, M. T., Russo, M., Guppi, S., Khaliullin, T. O., Iavicoli, I., Harper, M., et al. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126170 · Cited by 13
Niwa, K., Hashimoto, M., Lian, Z., Gao, J., Tagami, K., Yokoyama, Y., Mori, H., & Tamaya, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01300.x · Cited by 14
Zhu, Z., Liu, T., Han, F., Zhan, S., & Wang, C. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60331-9 · Cited by 12
Rodriguez, Y. I., Campos, L. E., Castro, M. G., Bannoud, N., Blidner, A. G., Filippa, V., Croci, D. O., Rabinovich, G. A., & Alvarez, S. E. (2020) · Cells · doi:10.3390/cells9112469 · Cited by 14
Aziz, M. H., Sundling, K. E., Dreckschmidt, N. E., & Verma, A. K. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.458 · Cited by 13
Infliximab inhibits DNA repair in ultraviolet B‐irradiated premalignant keratinocytes
Faurschou, A., Gniadecki, R., & Wulf, H. C. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00727.x · Cited by 12
Singh, A. K., Singh, A., Bauer, S. J., Wheeler, D. L., Havighurst, T. C., Kim, K., & Verma, A. K. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv162 · Cited by 13
Kuper, H., Τζώνου, Α., Kaklamani, E., Hsieh, C., Λάγιου, Π., Adami, H., Trichopoulos, D., & Stuver, S. O. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<503::aid-ijc10>3.0.co;2-l · Cited by 356
Disruption of CCL2 in Mesenchymal Stem Cells as an Anti-Tumor Approach against Prostate Cancer
Bui, Q. T., Lee, K., Fan, Y.-C., Lewis, B. S., Deng, L., & Tsai, Y. (2023) · Cancers · doi:10.3390/cancers15020441 · Cited by 11
Zoubi, M. S. A., Chipitsyna, G. I., Saxena, S., Sarosiek, K., Gandhi, A. V., Kang, C. Y., Relles, D. M., Sendecki, J. A., Hyslop, T., Yeo, C. J., et al. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2370-7 · Cited by 12
Role of the TNF‐α receptor type 1 on prostate carcinogenesis in knockout mice
Galheigo, M. R. U., Cruz, A. R., Cabral, Á. S., de Faria, P. R., Cordeiro, R. S., Silva, M. J. B., Tomiosso, T. C., Gonçalves, B. F., Pinto‐Fochi, M. E., Taboga, S. R., et al. (2016) · The Prostate · doi:10.1002/pros.23181 · Cited by 12
Mouse Models of Nonmelanoma Skin Cancer
Amberg, N., Holcmann, M., Glitzner, E., Novoszel, P., Stulnig, G., & Sibilia, M. C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_10 · Cited by 13
Choo, M., Kraft, S., Missero, C., & Park, J. M. (2018) · Science Signaling · doi:10.1126/scisignal.aau0727 · Cited by 11
Antitumor Necrosis Factor (TNF-a) Antibodies in the Treatment of Renal Cell Cancer
Maisey, N. R. (2007) · Cancer Investigation · doi:10.1080/07357900701359700 · Cited by 11
ALCAM is a Novel Cytoplasmic Membrane Protein in TNF-α Stimulated Invasive Cholangiocarcinoma Cells
Adisakwattana, P., Suwandittakul, N., Petmitr, S., Wongkham, S., Sangvanich, P., & Reamtong, O. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3849 · Cited by 12
Rothe, M., Quarcoo, D., Chashchina, A. A., Bozrova, S. V., Qin, Z., Nedospasov, S. A., Blankenstein, T. J. F., Kammertoens, T., & Drutskaya, M. S. (2013) · Cancer Medicine · doi:10.1002/cam4.145 · Cited by 10
Gao, C., Cai, X. M., Ma, L., Xue, T., & Li, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123912 · Cited by 11
Lipid Signaling in Tumorigenesis.
Liu, R., & Huang, Y. K. (2014) · PubMed · Cited by 11
Romero‐Reyes, M., Head, C. S., Cacalano, N. A., & Jewett, A. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0112-6 · Cited by 10
Lipid peroxidation and cell death mechanisms in rats and human cells induced by chloral hydrate
Ho, Y.-S., Ma, H.-Y., Chang, H.-Y., Wei, B.-L., Lee, C.-C., Ho, S. D., Guo, H., Wu, T.-P., Chang, W.-H., & Wang, Y. (2003) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00323-x · Cited by 11
Tracking the Road from Inflammation to Cancer: the Critical Role of IκB Kinase (IKK)
Karin, M. (2010) · Wiley eBooks · doi:10.1002/9780470593042.ch7 · Cited by 11
Mohammadzadeh, Z., Khaksari, M., Nematollahi, M. H., Kheirandish, R., Moslemizadeh, A., Delshad, S., Faramarz, S., Tezerji, S. S., Torkashvand, M., Shahba, S., et al. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf048 · Cited by 9
Schwarz, M., Thielmann, H. W., Meischner, V., & Fartasch, M. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.03.014 · Cited by 9
Fan, Y.-C., Chen, W., Lee, K., & Tsai, Y.-C. (2020) · Biology · doi:10.3390/biology9040067 · Cited by 9
Okumura, K., Saito, M., Yoshizawa, Y., Ito, Y., Isogai, E., Araki, K., & Wakabayashi, Y. (2020) · Oncogene · doi:10.1038/s41388-020-1323-3 · Cited by 10
Deepak, P., & Acharya, A. (2010) · International Reviews of Immunology · doi:10.3109/08830185.2010.483027 · Cited by 9
Konger, R. L., Derr-Yellin, E. C., Travers, J. B., Ocaña, J. A., & Sahu, R. P. (2017) · Oncotarget · doi:10.18632/oncotarget.21002 · Cited by 10
Gelfand, E. W., Simon, D., Simon, H., Thomas, P. A., Busse, W. W., Nair, P. K., Gauvreau, G. M., Denburg, J. A., Bivins-Smith, E. R., Jacoby, D. B., et al. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-394385-9.00013-4 · Cited by 10
Zhang, M., Hu, J., Li, H., Zhang, S., Hu, W., Wu, L., & Han, B. (2019) · Oncology Letters · doi:10.3892/ol.2019.10193 · Cited by 9
Wu, C.-H., Chen, H.-L., Su, H.-J. J., Lee, C. C., Shen, K.-T., Wl, H., Ho, S.-Y., Ho, Y.-S., & Wang, Y. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.02.022 · Cited by 10
Cellular and Molecular Mechanisms of Tumor Promotion
Rundhaug, J. E., & Fischer, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01416-0 · Cited by 13
The Roles of TNF Signaling Pathways in Metabolism of Bone Tumors
Zhou, H., Dong, Y., Alhaskawi, A., Lai, J., Wang, Z., Ezzi, S. H. A., Kota, V. G., Abdulla, M. H. A. H., Sun, Z.-Y. J., & Lu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.907629 · Cited by 12
Anti-Inflammatory Effects of Nano- Curcumin on a Glioblastoma Cell Line
Tondro, G., Rajabzade, G., Mohammadi, A., Moradi, H. R., & Negah, S. S. (2022) · The Neuroscience Journal of Shefaye Khatam · doi:10.52547/shefa.10.3.48 · Cited by 8
Wang, M., Yu, X., & Gao, Q. (2024) · Current Medical Science · doi:10.1007/s11596-024-2859-1 · Cited by 8
Effect of colon carcinoma cell supernatants on cytokine production and phagocytic capacity
Salman, H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00557-7 · Cited by 8
Liu, X., Zhang, J., Li, J., Volk, A. G., Breslin, P., Zhang, J., & Zhang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115490 · Cited by 8
Pan-cancer analysis of the prognostic value of C12orf75 based on data mining
Cai, G., Jin, G.-N., Liang, J., Li, G., Chen, X., Liang, H., & Ding, Z. (2021) · Aging · doi:10.18632/aging.203081 · Cited by 8
David, M. S., Kelly, E. W., Cheung, I., Xaymardan, M., Moore, M. A. S., & Zoellner, H. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101202 · Cited by 8
Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update
Segaert, S. (2009) · Journal of Inflammation Research · doi:10.2147/jir.s4405 · Cited by 8
Expression of CXC chemokine IP‐10 in testicular germ cell tumours
Schweyer, S., Soruri, A., Baumhoer, D., Peters, J. H., Cattaruzza, M., Radzun, H., & Fayyazi, A. (2002) · The Journal of Pathology · doi:10.1002/path.1094 · Cited by 8
Transposon-based mutagenesis identifies short RIP1 as an activator of NFκB
Dasgupta, M., Agarwal, M. K., Varley, P., Lu, T., Stark, G. R., & Kandel, E. (2008) · Cell Cycle · doi:10.4161/cc.7.14.6310 · Cited by 10
Possible association between gastric cancer and bracken fern in Venezuela: An epidemiologic study
Alonso‐Amelot, M. E., & Avendaño, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010115)91:2 · Cited by 66
Stewart, T. J., Lutsiak, M. E. C., & Abrams, S. I. (2008) · Cancer Investigation · doi:10.1080/07357900701708419 · Cited by 8
Re: Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
Balkwill, F. R. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.162a · Cited by 8
Self-citationEnergy imbalance and cancer: Cause or consequence?
Wang, X., Liu, W., & Xie, X. (2017) · IUBMB Life · doi:10.1002/iub.1674 · Cited by 7
Bauer, O., Hantisteanu, S., Lotem, J., & Groner, Y. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0098-t · Cited by 7
RBPJ inhibits the movability of endometrial carcinoma cells by miR-155/NF-κB/ROS pathway
Xiao, Y., Wang, X., Dong, X., Zhang, Y., & Liu, H. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s212519 · Cited by 7
Macrophage Metabolism at the Crossroad of Metabolic Diseases and Cancer
Yang, S., den Bossche, J. V., & Ramalho, T. R. D. O. (2020) · Immunometabolism · doi:10.20900/immunometab20200022 · Cited by 7
Kannaiyan, R., Surana, R., Myoung, E., Ramachandran, L., Sethi, G., & Kumar, A. P. (2012) · InTech eBooks · doi:10.5772/30444 · Cited by 7
Inflammation in Carcinogenesis
Ognjanovic, S., & Hainaut, P. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01420-2 · Cited by 8
Sustained Macrophage Reprogramming Is Required for CD8+ T cell–Dependent Long-Term Tumor Eradication
Jardim, C., Bica, M., Reis-Sobreiro, M., da Mota, A. T., Lopes, R., Pinto, M. F., Sousa, N. S., Mensurado, S., Boekhoff, H., Scolaro, T., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0797 · Cited by 7
Youssef, N., Habeeb, M., Chen, H., Alhamal, Z., Mamlouk, O., Lin, H. Y., Page, V. D., Tchakarov, A. S., Basu, S., Diab, A. K., et al. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.10.018 · Cited by 11
Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma
Yang, S., Yang, X., Hou, Z., Zhu, L., Yao, Z., Zhang, Y., Chen, Y., Teng, J., Fang, C., Chen, S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29215 · Cited by 10
Use of Moracin in preventing the cancer
Khyade, V. B. (2013) · IOSR Journal of Environmental Science Toxicology and Food Technology · doi:10.9790/2402-04596104 · Cited by 6
Sur, I., Ulvmar, M. H., Jungedal, R., & Toftgård, R. (2009) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890802679876 · Cited by 6
NADPH oxidase and reactive oxygen species as signaling molecules in carcinogenesis
Wang, G. (2009) · Frontiers of Medicine · doi:10.1007/s11684-009-0018-5 · Cited by 6
Induction of apoptosis and inhibition of papilloma formation may signal a new role for okadaic acid
Elegbede, J. A., Hayes, K., Schell, K. A., Oberley, T. D., & Verma, A. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01701-0 · Cited by 6
Redox Modulation in Tumor Initiation, Promotion, and Progression
Hanausek, M., Wałaszek, Z., & Slaga, T. J. (2003) · Oxidative stress and disease · doi:10.1201/9780203912874.ch9 · Cited by 7
Kim, G. H., Lee, S. Y., Oh, S., Jang, J.-W., Lee, J. H., Kim, H., Son, K. H., & Byun, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312522 · Cited by 6
Xia, X., Park, E., Fischer, S. M., & Hu, Y. (2013) · Cancers · doi:10.3390/cancers5010170 · Cited by 5
Asejeje, F. O., Etim, S., Asejeje, G. I., Iwuoh, B. C., Akintade, S. I., Adedara, I. A., & Farombi, E. O. (2023) · Nigerian Journal of Physiological Sciences · doi:10.54548/njps.v38i2.4 · Cited by 6
Subversion and Coercion: The Art of Redirecting Tumor Immune Surveillance
Mumm, J. B., & Oft, M. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_47 · Cited by 5
Dibra, D., Mitra, A., Newman, M., Xia, X., Keenan, C., Cutrera, J. J., Mathis, J. M., Wang, X., Myers, J. N., & Li, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12581 · Cited by 5
Martinez, R. M., Ivan, A. L. M., do Vale, D. L., Campanini, M. Z., Ferreira, V. S., Steffen, V. S., Vicentini, F. T. M. C., Vilela, F. M. P., Fonseca, M. J. V., Baracat, M. M., et al. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12997 · Cited by 5
Bacteria in Carcinogenesis and Cancer Prevention: A Review Study
Nokhandani, N., Poursheikhani, A., Alhosseini, M. N., & Davoodi, H. (2021) · International Journal of Cancer Management · doi:10.5812/ijcm.107956 · Cited by 6
Chokoeva, A. A., Tchernev, G., Lotti, T., & Wollina, U. (2015) · Dermatologic Therapy · doi:10.1111/dth.12221 · Cited by 5
Ono, R., Fukunaga, A., Masaki, T., Yu, X., Yodoi, J., & Nishigori, C. (2013) · Bioengineered · doi:10.4161/bioe.23612 · Cited by 5
Ramirez‐Montagut, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-416603-5.00015-8 · Cited by 8
Topical valrubicin application reduces skin inflammation in murine models
Hauge, E., Christiansen, H., Rosada, C., de Darkó, E., Dam, T. N., & Stenderup, K. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10964.x · Cited by 5
Squamous Cell Carcinoma of the Skin: Current Strategies for Treatment and Prevention
Bachelor, M. A., & Owens, D. M. (2009) · Current Cancer Therapy Reviews · doi:10.2174/157339409787314090 · Cited by 5
Self-citationPlant Polyphenols and Their Role in Cancer Prevention and Chemotherapy
Shankar, S., Singh, B. N., & Srivastava, R. K. (2012) · Springer eBooks · doi:10.1007/978-94-007-2923-0_10 · Cited by 5
Serum chitotriosidase: a circulating biomarker in polycythemia vera
Krečak, I., Gverić‐Krečak, V., Rončević, P., Bašić‐Kinda, S., Gulin, J., Lapić, I., Fumić, K., Ilić, I., Horvat, I., Zadro, R., et al. (2018) · Hematology · doi:10.1080/10245332.2018.1498157 · Cited by 6
Li, W., Yang, J.-H., Liu, L., Ding, S., Yu, B., Jiang, L., Yan, N., & Liu, H.-D. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1580029 · Cited by 10
Elliot, A. M., Bravo, I. R., Zhao, Y., Wang, Z., Johansson, J. A., Hutton, E., Cunningham, R., Myllymäki, H., Chang, K.-M., Cholewa-Waclaw, J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116478 · Cited by 6
Liu, M., Li, C., NaYan, Zhao, D., Zhang, H., Li, J., Tang, X., Liu, X., Deng, Y., & Song, Y. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-01959-2 · Cited by 6
NF-KappaB-Mediated Regulation of Tumour-Associated Macrophages: Mechanisms and Significance
Sica, A., & Mantovani, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0662-4_11 · Cited by 4
In vivo Growth Inhibition of Sarcoma-180 Cells by a β-Glucan from the Mushroom Ganoderma lucidum
Han, M., Kim, Y. H., & Kim, W.-J. (2014) · Journal of Life Science · doi:10.5352/jls.2014.24.7.721 · Cited by 4
UV immunosuppression and cutaneous malignancies
Jou, P. C., McCormick, T. S., & Baron, E. D. (2011) · Expert Review of Dermatology · doi:10.1586/edm.10.72 · Cited by 6
Sikka, S., Shanmugam, M. K., Kannaiyan, R., Surana, R., Shin, E. M., Kumar, A. P., Sethi, G., & Ahn, K. S. (2013) · Phytochemistry Reviews · doi:10.1007/s11101-013-9287-3 · Cited by 4
Chronic obstructive pulmonary disease and lung cancer: inflammation, the missing link
Gibbons, M., & Sethi, T. (2009) · Therapy · doi:10.2217/thy.09.77 · Cited by 5
Chakraborty, B. (2014) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000173 · Cited by 4
Impact of Haplotype TNF-LTA Locus with Susceptibility to Cervical Cancer in Indian Population
Kohaar, I., Hussain, S., Kumar, A., Singhal, P., Choudhury, S. R., Das, B. C., & Bharadwaj, M. (2014) · Obstetrics & Gynecology An International Journal · doi:10.5171/2014.831817 · Cited by 3
Metadata
- Authors
- Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., & Balkwill, F.
- Affiliations
- Hammersmith Hospital (GB)
- Harvard University (US)
- Pasteur Hellenic Institute (GR)
- Corresponding author
- Balkwill, Frances
- ORCID
- Venue
- Nature Medicine
- Published
- 1999-07
- Volume
- 5
- Issue
- 7
- Pages
- 828-831
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1585093254
- Cited by
- 839
- References
- 21
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 8 · 2023: 20 · 2022: 15 · 2021: 19 · 2020: 26 · 2019: 18 · 2018: 16 · 2017: 19 · 2016: 37 · 2015: 32 · 2014: 46 · 2013: 44 · 2012: 41
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TNF-α, skin carcinogenesis, TNF-alpha knockout mice, tumor promotion, 7,12-dimethylbenz(a)anthracene, tissue plasminogen activator, keratinocyte hyperproliferation, skin inflammation, chemokines, malignant progression, chronic inflammation and cancer, cancer prevention
- MeSH terms
- Animals, Crosses, Genetic, Female, Immunity, Innate, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred Strains, Neoplasm Invasiveness, Neoplasm Staging, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, Tumor Necrosis Factor-alpha, 9,10-Dimethyl-1,2-benzanthracene, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.